Sai Life Sciences Has Begun Commercial Operations of Second Phase of Bidar, India Unit Expansion

MT Newswires Live

2025/06/20

Sai Life Sciences (NSE:SAILIFE, BOM:544306) has begun commercial operations of the second phase of the production block with 91 kiloliter of capacity at its Bidar facility in Karnataka, India.

This is the second and final phase of the unit's overall capacity addition of 195 kiloliter, according to a Friday filing to the Indian stock exchanges.

With this, the combined capacity of Unit IV Bidar facility will be 640 kiloliter, which will supply to registered starting materials (RSM), intermediates, and active pharmaceutical ingredients (APIs) for clinical and commercial purposes.

The company's shares were up nearly 1% in recent trade.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2544114585"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2544114585\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2544114585?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-06-20 15:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2544114585","market":"sh","top_or_hot":-1,"title":"Sai Life Sciences Has Begun Commercial Operations of Second Phase of  Bidar, India Unit Expansion","media":"MT Newswires Live","content":"<html><body><p> Sai Life Sciences (NSE:SAILIFE, BOM:544306) has begun commercial operations of the second phase of the production block with 91 kiloliter of capacity at its Bidar facility in Karnataka, India.</p><p>This is the second and final phase of the unit's overall capacity addition of 195 kiloliter, according to a Friday filing to the Indian stock exchanges.</p><p>With this, the combined capacity of Unit IV Bidar facility will be 640 kiloliter, which will supply to registered starting materials (RSM), intermediates, and active pharmaceutical ingredients (APIs) for clinical and commercial purposes.</p><p>The company's shares were up nearly 1% in recent trade.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sai Life Sciences Has Begun Commercial Operations of Second Phase of  Bidar, India Unit Expansion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSai Life Sciences Has Begun Commercial Operations of Second Phase of  Bidar, India Unit Expansion\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-06-20 15:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Sai Life Sciences (NSE:SAILIFE, BOM:544306) has begun commercial operations of the second phase of the production block with 91 kiloliter of capacity at its Bidar facility in Karnataka, India.</p><p>This is the second and final phase of the unit's overall capacity addition of 195 kiloliter, according to a Friday filing to the Indian stock exchanges.</p><p>With this, the combined capacity of Unit IV Bidar facility will be 640 kiloliter, which will supply to registered starting materials (RSM), intermediates, and active pharmaceutical ingredients (APIs) for clinical and commercial purposes.</p><p>The company's shares were up nearly 1% in recent trade.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"FT_SY_MND","symbol_name":"MSCI 印度（美元）指数","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2544114585","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2544114585","pubTimestamp":1750404628,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Sai Life Sciences  has begun commercial operations of the second phase of the production block with 91 kiloliter of capacity at its Bidar facility in Karnataka, India.This is the second and final phase of the unit's overall capacity addition of 195 kiloliter, according to a Friday filing to the Indian stock exchanges.With this, the combined capacity of Unit IV Bidar facility will be 640 kiloliter, which will supply to registered starting materials , intermediates, and active pharmaceutical ingredients  for clinical and commercial purposes.The company's shares were up nearly 1% in recent trade.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"RSM.AU":"RUSSELL INVEST AUST SEMI-GOV"},"translate_title":"Sai Life Sciences印度比达尔装置扩建第二阶段已开始商业运营","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RSM.AU":1,"MNDmain":1},"content_text":"Sai Life Sciences (NSE:SAILIFE, BOM:544306) has begun commercial operations of the second phase of the production block with 91 kiloliter of capacity at its Bidar facility in Karnataka, India.This is the second and final phase of the unit's overall capacity addition of 195 kiloliter, according to a Friday filing to the Indian stock exchanges.With this, the combined capacity of Unit IV Bidar facility will be 640 kiloliter, which will supply to registered starting materials (RSM), intermediates, and active pharmaceutical ingredients (APIs) for clinical and commercial purposes.The company's shares were up nearly 1% in recent trade.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}